p38alpha MAP kinase C-terminal domain binding pocket characterized by crystallographic and computational analyses.
暂无分享,去创建一个
Arthur J. Olson | John A. Tainer | Rodney M. Harris | J. Tainer | A. Olson | J. Perry | Rodney Harris | D. Moiani | Davide Moiani | J. Jefferson P. Perry
[1] Radha Akella,et al. Substrate and docking interactions in serine/threonine protein kinases. , 2007, Chemical reviews.
[2] Stefano Trapani,et al. AMoRe: classical and modern , 2007, Acta crystallographica. Section D, Biological crystallography.
[3] Radha Akella,et al. Unique MAP Kinase binding sites. , 2008, Biochimica et biophysica acta.
[4] Jui‐I Chao,et al. Regulation of gamma-H2AX and securin contribute to apoptosis by oxaliplatin via a p38 mitogen-activated protein kinase-dependent pathway in human colorectal cancer cells. , 2008, Toxicology letters.
[5] David S. Goodsell,et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998 .
[6] J. Tainer,et al. A mutation in the human cyclin-dependent kinase interacting protein, CksHs2, interferes with cyclin-dependent kinase binding and biological function, but preserves protein structure and assembly. , 1996, Journal of molecular biology.
[7] L. Tong,et al. Crystallization and preliminary crystallographic analysis of recombinant human p38 MAP kinase , 1997, Protein science : a publication of the Protein Society.
[8] D. Kipling,et al. Werner Syndrome as an example of inflamm-aging: possible therapeutic opportunities for a progeroid syndrome? , 2006, Rejuvenation research.
[9] J. Tainer,et al. Biogenesis of chemotactic molecules by the arachidonate lipoxygenase system of platelets , 1975, Nature.
[10] John A. Tainer,et al. X-ray solution scattering (SAXS) combined with crystallography and computation: defining accurate macromolecular structures, conformations and assemblies in solution , 2007, Quarterly Reviews of Biophysics.
[11] Y. Lee,et al. Corrigendum to “Regulation of gamma-H2AX and securin contribute to apoptosis by oxaliplatin via a p38 mitogen-activated protein kinase-dependent pathway in human colorectal cancer cells” [Toxicol. Lett. 179 (June(2)) (2008) 63–70] , 2008 .
[12] Gabriella De Vita,et al. p38α MAP Kinase as a Sensor of Reactive Oxygen Species in Tumorigenesis , 2007 .
[13] J. Madwed,et al. Structure-activity relationships of the p38alpha MAP kinase inhibitor 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)naph- thalen-1-yl]urea (BIRB 796). , 2003, Journal of medicinal chemistry.
[14] L. Bardwell,et al. Mechanisms of MAPK signalling specificity. , 2006, Biochemical Society transactions.
[15] David S. Goodsell,et al. Automated docking of ligands to an artificial active site: augmenting crystallographic analysis with computer modeling , 2003, J. Comput. Aided Mol. Des..
[16] L. Tong,et al. A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket , 1997, Nature Structural Biology.
[17] S. Reed,et al. A kinase-independent function of Cks1 and Cdk1 in regulation of transcription. , 2005, Molecular cell.
[18] Andrew D Sharrocks,et al. ERK5 is targeted to myocyte enhancer factor 2A (MEF2A) through a MAPK docking motif. , 2004, The Biochemical journal.
[19] F. Wyllie,et al. The Role of Cellular Senescence in Werner Syndrome , 2007, Annals of the New York Academy of Sciences.
[20] Jiahuai Han,et al. Phosphatidylinositol Ether Lipid Analogues That Inhibit AKT Also Independently Activate the Stress Kinase, p38α, through MKK3/6-independent and -dependent Mechanisms* , 2007, Journal of Biological Chemistry.
[21] A. Cuadrado,et al. p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis. , 2007, Cancer cell.
[22] J. Tainer,et al. Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase , 2008, Nature chemical biology.
[23] J. Shelhamer,et al. Leukotriene D(4) induces gene expression in human monocytes through cysteinyl leukotriene type I receptor. , 2008, The Journal of allergy and clinical immunology.
[24] A. Doweyko,et al. Structural comparison of p38 inhibitor-protein complexes: a review of recent p38 inhibitors having unique binding interactions. , 2005, Current topics in medicinal chemistry.
[25] Ron Diskin,et al. A novel lipid binding site formed by the MAP kinase insert in p38 alpha. , 2008, Journal of molecular biology.
[26] S. Klassen,et al. Ceramide activates a mitochondrial p38 mitogen-activated protein kinase: A potential mechanism for loss of mitochondrial transmembrane potential and apoptosis , 2005, Molecular and Cellular Biochemistry.
[27] S. Colowick,et al. Methods in Enzymology , Vol , 1966 .
[28] SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS , 1998 .
[29] Z. Otwinowski,et al. [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[30] John C. Lee,et al. p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines. , 2001, Progress in medicinal chemistry.
[31] Jui‐I Chao,et al. Activation of p38 mitogen-activated protein kinase by celecoxib oppositely regulates survivin and gamma-H2AX in human colorectal cancer cells. , 2007, Toxicology and applied pharmacology.
[32] B. Kamińska. MAPK signalling pathways as molecular targets for anti-inflammatory therapy--from molecular mechanisms to therapeutic benefits. , 2005, Biochimica et biophysica acta.
[33] John A Tainer,et al. Crystal Structure and Mutational Analysis of the Human CDK2 Kinase Complex with Cell Cycle–Regulatory Protein CksHs1 , 1996, Cell.
[34] D. Lawrence,et al. Multiple Regions of MAP Kinase Phosphatase 3 Are Involved in Its Recognition and Activation by ERK2* , 2001, The Journal of Biological Chemistry.
[35] E. Goldsmith,et al. Structural basis of inhibitor selectivity in MAP kinases. , 1998, Structure.
[36] L. Pearl,et al. Structural basis for recruitment of glycogen synthase kinase 3β to the axin—APC scaffold complex , 2003, The EMBO journal.
[37] Discovering new MAP kinase inhibitors. , 2006, Chemistry & biology.
[38] P. Dennis,et al. Novel PI analogues selectively block activation of the pro-survival serine/threonine kinase Akt. , 2003, Journal of the American Chemical Society.
[39] M. Miloso,et al. Neurotoxicity of Platinum Compounds: Comparison of the Effects of Cisplatin and Oxaliplatin on the Human Neuroblastoma Cell Line SH-SY5Y , 2004, Journal of Neuro-Oncology.
[40] D. Goodsell,et al. Automated prediction of ligand‐binding sites in proteins , 2007, Proteins.
[41] A. Cuenda,et al. p38 MAP-kinases pathway regulation, function and role in human diseases. , 2007, Biochimica et biophysica acta.
[42] J. Blank,et al. p38 Mitogen-activated protein kinase mediates cell death and p21-activated kinase mediates cell survival during chemotherapeutic drug-induced mitotic arrest. , 2003, Molecular biology of the cell.
[43] Ricardo M Biondi,et al. Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions. , 2003, The Biochemical journal.
[44] Lifeng Geng,et al. Synthesis, crystal structure, and activity of pyrazole-based inhibitors of p38 kinase. , 2007, Journal of medicinal chemistry.
[45] J. Tainer,et al. Screening a peptidyl database for potential ligands to proteins with side‐chain flexibility , 1998, Proteins.
[46] D S Goodsell,et al. Automated docking of flexible ligands: Applications of autodock , 1996, Journal of molecular recognition : JMR.
[47] Hui-yu Liu,et al. p38 Mitogen-activated Protein Kinase Mediates Free Fatty Acid-induced Gluconeogenesis in Hepatocytes* , 2006, Journal of Biological Chemistry.
[48] David S. Goodsell,et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..
[49] E. Nishida,et al. A conserved docking motif in MAP kinases common to substrates, activators and regulators , 2000, Nature Cell Biology.
[50] Z. Otwinowski,et al. Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[51] L. Johnson,et al. Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phosphoCDK2. , 2001, Molecular cell.
[52] Jiahuai Han,et al. Mitogen‐activated protein kinase p38 defines the common senescence‐signalling pathway , 2003, Genes to cells : devoted to molecular & cellular mechanisms.
[53] E. Goldsmith,et al. The structure of mitogen-activated protein kinase p38 at 2.1-A resolution. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[54] J. Tainer,et al. Crystal structures of a schistosomal drug and vaccine target: glutathione S-transferase from Schistosoma japonica and its complex with the leading antischistosomal drug praziquantel. , 1995, Journal of molecular biology.
[55] Masahiko Hibi,et al. c-Jun Can Recruit JNK to Phosphorylate Dimerization Partners via Specific Docking Interactions , 1996, Cell.
[56] J. Boehm,et al. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases , 2003, Nature Reviews Drug Discovery.
[57] Susan S. Taylor,et al. Regulation of protein kinases; controlling activity through activation segment conformation. , 2004, Molecular cell.
[58] Michel F. Sanner,et al. Hierarchical and multi-resolution representation of protein flexibility , 2006, Bioinform..
[59] John A Tainer,et al. Full‐length archaeal Rad51 structure and mutants: mechanisms for RAD51 assembly and control by BRCA2 , 2003, The EMBO journal.
[60] H. Saito,et al. Conserved docking site is essential for activation of mammalian MAP kinase kinases by specific MAP kinase kinase kinases. , 2005, Molecular cell.
[61] L. Mahadevan,et al. Anisomycin Selectively Desensitizes Signalling Components Involved in Stress Kinase Activation and fos andjun Induction , 1998, Molecular and Cellular Biology.
[62] R J Read,et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.
[63] C. Murga,et al. Interfering with MAP Kinase Docking Interactions: Implications and Perspectives for the p38 Route , 2007, Cell cycle.
[64] Y-T Chen,et al. Areca nut extracts-activated secretion of leukotriene B4, and phosphorylation of p38 mitogen-activated protein kinase and elevated intracellular calcium concentrations in human polymorphonuclear leukocytes. , 2007, Journal of periodontal research.
[65] D E McRee,et al. XtalView/Xfit--A versatile program for manipulating atomic coordinates and electron density. , 1999, Journal of structural biology.
[66] J. Tainer,et al. Structural Basis for FEN-1 Substrate Specificity and PCNA-Mediated Activation in DNA Replication and Repair , 2004, Cell.
[67] A. Sharrocks,et al. Docking domains and substrate-specificity determination for MAP kinases. , 2000, Trends in biochemical sciences.
[68] M. Karin,et al. Mammalian MAP kinase signalling cascades , 2001, Nature.
[69] A. Sharrocks,et al. Selective Targeting of MAPKs to the ETS Domain Transcription Factor SAP-1* , 2001, The Journal of Biological Chemistry.
[70] John A Tainer,et al. DNA double-strand break repair from head to tail. , 2002, Current opinion in structural biology.
[71] O. Werz,et al. p38 MAP kinase mediates stress‐induced leukotriene synthesis in a human B‐lymphocyte cell line , 2001, Journal of leukocyte biology.